Paris-based multinational Cooper Consumer Health has initiated pre-launch activities for Eroxon, a drug free OTC erectile dysfunction gel.
Developed by and licensed from UK R&D firm Futura Medical, Eroxon is expected to hit shelves in Europe during the...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?